Logos Global Management
VOR icon

Logos Global Management’s Vor Biopharma VOR Stock Holding History

Logos Global Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
650,000
-100,000
-13% -$1.51M 0.52% 45
2026
Q1 		$13.4M Buy
750,000
+650,000
+650% +$9.17M 0.67% 43
2025
Q4 		$1.31M Buy
+100,000
New +$1.86M 0.08% 65

Other funds holding VOR

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCPM III Services
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Logos Global Management's VOR Position: Q2 2026 in Review

Logos Global Management reduced its Vor Biopharma (VOR) stake by 13% in Q2 2026, selling an estimated $1.51M and leaving 650,000 shares worth $12M. The position accounts for 0.52% of the portfolio, ranked #45.

Logos Global Management first reported a position in VOR in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.4M in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Logos Global Management held 650,000 shares of Vor Biopharma worth $12M as of Q2 2026.
  • Logos Global Management sold 100,000 Vor Biopharma shares in Q2 2026, an estimated $1.51M.
  • Vor Biopharma made up 0.52% of Logos Global Management's portfolio in Q2 2026, its #45 holding.
  • Logos Global Management first reported a position in Vor Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Logos Global Management's Vor Biopharma position peaked at $13.4M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.